VECT-HORUS recognized as a newcomer to the theranostic field by Labiotech

Vect-Horus mentioned as a relative newcomer to the theranostic field with a high potential in “Radiopharmaceuticals Gain Traction for Cancer Theranostics Potential” article by Labiotech - Europe’s Leading Biotech news website.

Full article available at https://www.labiotech.eu/cancer/theranostics-radiopharmaceuticals-nuclear-medicine/